March 2, 2026

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: An 84.90% Revenue Surge and 37.27% Upside Potential

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering entity in RNA interference therapeutics, has been generating buzz in the biotechnology sector with its impressive revenue growth and significant upside potential. Based..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 34.15% Upside Potential in the Healthcare Sector

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $34.41 billion, Agilent is..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 12.36% Upside Beckons in Healthcare Innovation

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the healthcare sector, has long stood at the forefront of the drug manufacturing industry, particularly specializing in generic and specialty medicines...

Hologic, Inc. (HOLX) Stock Analysis: Navigating Growth in the Medical Instruments Sector

Hologic, Inc. (NASDAQ: HOLX) stands at the forefront of the healthcare sector, specializing in medical instruments and supplies with a primary focus on women’s health. With a market cap of..

AptarGroup, Inc. (ATR) Stock Analysis: An Investor’s Guide to a 12% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leading player in the medical instruments and supplies industry, presents a compelling investment opportunity with a potential upside of 12.33%, as suggested by analyst ratings...

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 2.09% Dividend Yield Amid Market Dynamics

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, stands as a stalwart among drug manufacturers in the United States. With a staggering market capitalization of $598.69 billion,..

BioMarin Pharmaceutical (BMRN) Stock Analysis: Exploring a 42.84% Potential Upside Amidst Robust Growth

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is making waves in the biotechnology sector, attracting the attention of individual investors with its promising outlook and notable growth metrics. With a market capitalization..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Potential 27.89% Upside Amid Robust Growth and Strategic Positioning

As investors navigate the complex landscape of the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) stands out as a formidable player within the diagnostics and research industry. With a..

United Therapeutics (UTHR): Investor Outlook with a 13% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR) remains a compelling focus for investors in the healthcare sector, particularly those interested in the specialty and generic drug manufacturing industry. With a market capitalization..

Tenet Healthcare Corporation (THC) Stock Analysis: A Strong Buy with 7.36% Potential Upside

Tenet Healthcare Corporation (NYSE: THC) stands as a prominent player in the U.S. healthcare sector, showcasing impressive growth and robust market positioning. With a market capitalization of $21.04 billion, Tenet..

Stryker Corporation (SYK) Stock Analysis: A Healthcare Giant with Promising Upside Potential

Stryker Corporation (NYSE: SYK), a heavyweight in the healthcare sector, is widely recognized for its innovative contributions to medical devices. With a robust market capitalization of $148.28 billion, Stryker stands..

West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Promising 25% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) offers a compelling opportunity for investors looking to capitalize on the robust growth and innovation in the healthcare sector. Specializing in the design and..

Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals

Investors seeking opportunities in the healthcare sector may find Solventum Corporation (NYSE: SOLV) an intriguing prospect. This Maplewood, Minnesota-based company, with a market cap of $12.87 billion, operates in the..

Baxter International Inc. (BAX) Stock Analysis: Navigating Opportunities with a 6.20% Potential Upside

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently at a pivotal point for investors seeking value amidst fluctuating market conditions. With a market capitalization..

Boston Scientific Corporation (BSX) Stock Analysis: With a 36.3% Potential Upside, Is It Time to Invest?

Boston Scientific Corporation (NYSE: BSX), a leading player in the medical devices sector, is capturing investor interest with its robust growth metrics and promising analyst ratings. As of the latest..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with 8.50% Upside Potential

In the ever-evolving landscape of healthcare, Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, presents itself as a formidable contender in the medical distribution industry. With a robust market..

Cardinal Health, Inc. (CAH) Investor Outlook: Strong Growth Potential with 8.54% Upside

Cardinal Health, Inc. (NYSE: CAH) is making headlines in the healthcare sector as a formidable player in medical distribution. With a market capitalization of $53.94 billion, this Dublin, Ohio-based company..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth with a Potential 4.28% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $19.51 billion, Zimmer Biomet..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 9.86% Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a leader in precision instruments and services, stands out in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, the..

Veeva Systems Inc. (VEEV) Stock Analysis: Uncovering a 61% Potential Upside Opportunity

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions tailored for the life sciences sector, presents a compelling investment case for those seeking growth-oriented opportunities in the healthcare technology..

Search

Funds

March 2, 2026

Search

Funds

March 2, 2026

FTSE 100

Funds